TRIT1-MFSD2A Fusion FISH Probe
The TRIT1-MFSD2A Fusion FISH Probe is used to confirm a fusion of the TRIT1 and MFSD2A genes. The fusion of the TRIT1 and MFSD2A genes has been associated with Kidney Renal Clear Cell Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| TRIT1-MFSD2A-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-RERE | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-REOR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-REGO | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-REGR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-OROR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GORE | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GROR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| TRIT1-MFSD2A-20-AQAQ | 20 (40 μL) | 200 μL |
|
TRIT1 Gene Summary
This gene encodes a protein that that is targeted to the mitochondrion and modifies transfer RNAs (tRNAs) by adding a dimethylallyl group onto the adenine at position 37. This modification is important for maintaining the correct reading frame during protein translation. This gene is considered a tumor suppressor and its expression can decrease cell growth. Alternative splicing results in multiple transcripts variants, most of which are likely non-functional. [provided by RefSeq, Aug 2015]
Gene Name: TRNA Isopentenyltransferase 1
Chromosome: CHR1: 40306705 -40349177
Locus: 1p34.2
MFSD2A Gene Summary
The protein encoded by this gene is a transmembrane protein and sodium-dependent lysophosphatidylcholine transporter. The encoded protein is involved in the establishment of the blood-brain barrier and is required for brain growth and function. Defects in this gene are a cause of a progressive microcephaly syndrome. [provided by RefSeq, Mar 2017]
Gene Name: Major Facilitator Superfamily Domain Containing 2A
Chromosome: CHR1: 40420783 -40435628
Locus: 1p34.2
Gene Diseases
The TRIT1 MFSD2A Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Kidney Renal Clear Cell Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|